Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-89,001
Closed -$7.03M 253
2025
Q4
$7.03M Buy
+89,001
New +$7.04M 0.65% 47
2022
Q2
Sell
-74,270
Closed -$5.22M 277
2022
Q1
$5.22M Buy
+74,270
New +$5.02M 0.62% 56
2017
Q1
Sell
-9,369
Closed -$450K 265
2016
Q4
$450K Buy
+9,369
New +$430K 0.1% 114
2014
Q2
Sell
-9,270
Closed -$436K 94
2014
Q1
$436K Sell
9,270
-82,905
-90% -$3.81M 0.23% 59
2013
Q4
$4.43M Sell
92,175
-1,946
-2% -$87.2K 1.61% 16
2013
Q3
$3.94M Sell
94,121
-29,108
-24% -$1.25M 1.59% 19
2013
Q2
$5.03M Buy
+123,229
New +$4.53M 2.46% 8

Other funds holding MET

L & S Advisors's MET Position: Q1 2026 in Review

L & S Advisors sold out of MetLife (MET) in Q1 2026, closing a stake of 89,001 shares — an estimated $7.03M sold.

L & S Advisors first reported a position in MET in Q2 2013 and held it in 7 quarters. The position peaked at $7.03M in Q4 2025. 1,382 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • L & S Advisors reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • L & S Advisors sold 89,001 MetLife shares in Q1 2026, an estimated $7.03M.
  • L & S Advisors first reported a position in MetLife in Q2 2013 and held it in 7 quarters.
  • L & S Advisors's MetLife position peaked at $7.03M in Q4 2025.
  • 1,382 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on L & S Advisors's 13F filing for Q1 2026, filed 11 May 2026.